EMEA-002133-PIP01-17-M03
Key facts
| Invented name |
Fetcroja
|
| Active substance |
Cefiderocol
|
| Therapeutic area |
Infectious diseases
|
| Decision number |
P/0441/2022
|
| PIP number |
EMEA-002133-PIP01-17-M03
|
| Pharmaceutical form(s) |
Powder for concentrate for solution for infusion
|
| Condition(s) / indication(s) |
Treatment of infections due to aerobic Gram-negative bacteria
|
| Route(s) of administration |
Intravenous use
|
| Contact for public enquiries |
Shionogi Limited
E-mail: shionogiclintrials-admin@shionogi.co.jp |
| Decision type |
PM: decision on the application for modification of an agreed PIP
|